{
    "Trade/Device Name(s)": [
        "Aldolase Control Level 2",
        "Aldolase Control Level 3"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K131776",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000875"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "July 18, 2013",
    "Summary Letter Received Date": "June 17, 2013",
    "Submission Date": "June 10, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Single (Specified) Analyte Controls"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Aldolase"
    ],
    "Specimen Type(s)": [
        "Human Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RX Daytona",
        "Beckman Coulter AU640",
        "clinical chemistry analyzers indicated in the package insert"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Aldolase Control Level 2 and Level 3 as quality control materials for aldolase measurement on clinical chemistry analyzers",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as assayed quality control materials for the quantitative determination of aldolase on clinical chemistry analyzers; for prescription use only",
    "fda_folder": "Clinical Chemistry"
}